Antihyperglycemic, antihyperlipidemic and antioxidant activities of traditional aqueous extract of Zygophyllum album in streptozotocin diabetic mice

Pathophysiology

Volumn 19, Issue 1, 2012, Pages 35-42

  Ghoul, Jamel El ^a   Smiri, Moêz ^a   Ghrab, Saad ^b   Boughattas, Naceur A ^c   Ben Attia, Mossadok ^a  

^a University of Carthage   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Antioxidants; Diabetes mellitus; Liver; Mice; Pancreas; Plasma lipid; Streptozotocin; Zygophyllum album

Indexed keywords

ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; GLICLAZIDE; GLUCOSE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ZYGOPHYLLUM ALBUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIHYPERLIPIDEMIC; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER LEVEL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; ZYGOPHYLLACEAE; ZYGOPHYLLUM ALBUM;

EID: 84857450773     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2011.12.001     Document Type: Article

References (59)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projection. Diabetes Care 1998, 21:1414-1431.
2. Li W.L., Zheng H.C., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 2004, 92:1-21.
3. Stadler K., Jenei V., Bölcshazy G.V., Somogyi A., Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic. Biol. Med. 2003, 35:1240-1251.
4. Ramakrishna V., Sarojamma V., Jailkhani R., Srinivasulu V. Free radical activity and antioxidant defense status in Non Insulin Dependent Diabetes Mellitus (NIDDM) patients. Res. J. Intern. Med. 2006.
5. Karunanayake E.H., Tennekoon K.H. Search of novel hypoglycemic agents from medicinal plants. Diabetes Mellitus and its Complications. An Update 1993, Macmillan India Ltd., New Delhi, India. A.K. Sharma (Ed.).
6. Patel K., Srinivasan K. Plant foods in the management of diabetes mellitus: vegetables as potential hypoglycemic agents. Nahrung 1997, 41:68-74.
7. Narayana D.B., Dobriyal R.M. Complimentary medicines and 21st century therapeutics: challenges for pharmacologist. Pharmacology and Therapeutics in the New Millennium 2000, 326-335. Narosa Publishing House, New Delhi, India. S.K. Gupta (Ed.).
8. Yamagishi N., Nakayama K., Wakatsuki T., Hatayama T. Characteristic changes of stress protein expression in streptozotocin induced diabetic rats. Life Sci. 2001, 9:2603-2609.
9. Ugochukwu N.H., Babady N.E. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci. 2003, 73:1925-1938.
10. Shokeen P., Anand P., Murali Y.K., Tandon V. Antidiabetic activity of 50% ethanolic extract of Ricinus communis and its purified fractions. Food Chem. Toxicol. 2008, 46:3458-3466.
11. Esmaeili A.M., Yazdanparast R. Hypoglycaemic effects of Teucrium polium: studies with rat pancreatic islets. J. Ethnopharmacol. 2004, 95:27-30.
12. Jouhari J.T., Lazrek H.B., Jana M. The hypoglycemic activity of Zygophyllum gaetullum extracts in alloxan-induced hyperglycemic rats. J. Ethnopharmacol. 2000, 69:17-20.
13. Gibbons S., Oriowo M.A. The anti-hypertensive effects of Zygophyllum coccineum extracts in rats. Phytother. Res. 2001, 15:452-455.
14. Stefek M., Tribulova N., Gajdoski A., Gajdosikova A. The pyridoindole antioxidant stobadine attenuates histochemical changes in kidney of STZ-induced diabetic rats. Acta Histochem. 2002, 104:413-417.
15. Kalendra B., Oztruk M., Tuncdemir M., Usyal O., Dagistanli F.K., Yagenaga I., Erek E. Renoprotective effect of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem. 2002, 104:123-130.
16. Kim M.J., Ryu G.R., Chung J.S., Sim S.S., Min Dos Rhie D.J., Yoon S.H., Hahn S.J., Kim M.S., Jo Y.M. Protective effect of epicatechin against the toxic effects of STZ on rat pancreatic islets: in vivo and in vitro. Pancreas 2003, 26:292-299.
17. Weiss R.B. Streptozotocin: a review of its pharmacology, efficacy and toxicity. Cancer Treat. Rep. 1982, 66:427-438.
18. Chinnaswamy N., Fairbairn L.J., Laher J., Willington M.A., Rafferty J.A. Modulation of O6 alkylating agent induced clastogenecity by enhanced DNA repair capacity of bone marrow cells. Mutat. Res. 1998, 416:1-10.
19. Maritim A.C., Sanders R.A., Watkins J.B. Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J. Nutr. Biochem. 2003, 14:288-294.
20. Mullarkey C.J., Edelstein D., Brownlee L. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 1990, 173:932-939.
21. McLennan S.V., Heffernen S., Wright L. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991, 40:344-348.
22. Thomas S.R., Chen K., Keaney J.F. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid. Redox Signal. 2003, 5:181-194.
23. Wassmann S., Wassmann K., Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004, 44:381-386.
24. Strain J.J. Disturbances of micronutrient and antioxidant status in diabetes. Proc. Nutr. Soc. 1991, 50:591-604.
25. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
26. Young I.S., Torney J.J., Trimble E.R. The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic. Biol. Med. 1991, 8:752-758.
27. Soto C., Recoba R., Barron H., Alvarez C., Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp. Biochem. Physiol. 2003, 136:205-212.
28. Gul M., Kutay F.Z., Temocin S., Hanninen O. Cellular and clinical implications of glutathione. Indian J. Exp. Biol. 2000, 38(7):625-634.
29. Sekar N., Kanthasamy S., William S., Subramanian S., Govindasamy S. Insulinic actions of vanadate in diabetic rats. Pharm. Res. 1990, 22:207-217.
30. Siddique O., Sun Y., Lin J.C., Chien Y.W. Facilité de transport transdermique de l'insuline. J. Pharm. Sci. 1987, 76:341-345.
31. Sasaki T., Matsy S., Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsh Kagaku 1972, 1:346-353.
32. Desai E.D. Vitamin E analysis methods for animal tissue. Methods Enzymol. 1984, 105:138-142.
33. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol. 1971, 62:3-11.
34. Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
35. Sedlak J., Lindsay R.H. Estimation of total, protein bound and non protein sulfhydryl groups in tissuewith Ellman's reagent. Anal. Biochem. 1968, 25:192-205.
36. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
37. Aebi H. Catalase in vitro. Methods Enzymol 1984, vol. 105:121-126. Academic Press, New York.
38. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
39. Yadav J.P., Saini S., Kalia A.N., Dangi A.S. Hypoglycemic and hypolipidemic activity of ethanolic extract of Salvodora oleoides in normal and alloxan-induced diabetic rats. Indian J. Pharmacol. 2008, 1:23-27.
40. Bnouham M., Mekhfi H., Legssyer A., Ziyyat A. Ethnopharmacology forum medicinal plants used in the treatment of diabetes in Morocco. Int. J. Diabetes Metabol. 2002, 10:33-50.
41. Atta A.H., Nasr S.M., Mouneir S.M. Antiulcerogenic effect of some plants extracts. Nat. Prod. Rad. 2005, 4:258-263.
42. Khabbal Y., Ait El Cadi M., Alaoui K., Faouzi Mg.A., Cherrah Y. Activité anti-inflammatoire de zygophyllum gaetulum. Phytotherapie 2006, 5:227-229.
43. Smati D., Longeon A., Guyot M. 3 Beta-(3,4-dihydroxycinnamoyl)-erythrodiol, a cytotoxic constituent of Zygophyllum geslini collected in the Algerian Sahara. J. Ethnopharmacol. 2004, 95:405-407.
44. Skim F., Lazrek H.B., Kaaya A., El Amri H., Jana M. Pharmacological studies of two antidiabetic plants: Globularia alypum and Zygophyllum gaetulum. Thérapie 1999, 54:711-715.
45. Kakkar A., Chinswangwatanakul V., Lemoine N.R. Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma. Br. J. Surg. 1999, 86:890-894.
46. Evans P., Halliwell B. Micronutrients: oxidant/antioxidant status. Br. J. Nutr. 2001, 85:67-74.
47. Berger M. Nutritional manipulation of oxidative stress: review of the evidence. Nutr. Clin. Métab. 2006, 20:48-53.
48. Davidson M.B. Diabetes Mellitus: Diagnosis and Treatment 1981, Wiley, Hoboken, NJ, p. 109.
49. Singh S.K., Kesari A.N., Gupta R.K., Jaiswal D., Watal G. Assessment of antidiabetic potential of cynodondactylon extract in streptozotocin diabetic rats. J. Ethnopharmacol. 2007, 114:174-179.
50. Ghule B.V., Ghante M.H., Saoji A.N., Yeole P.G. Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand.fruit in hyperlipidemic rats. J. Ethnopharmacol. 2009, 2:333-337.
51. Kasetti R.B., Rajasekhar M.D., Kondeti V.K., Fatima S.S., Kumar E.G., Swapna S., Ramesh B., Rao C.A. Antihyperglycemic and antihyperlipidemic activities of methanol:water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats. Food Chem. Toxicol. 2010, 4:1078-1084.
52. Cooperstin S.J., Watkin D. Action of Toxic Drugs on Islet Cells. In the Islets of Langerhans 1981, Academic Press, New York, pp. 387-425.
53. Al-Shamaony L., Al Khazraji M.S., Twaij H.A. Hypoglycemic effects of Artemisia herba-alba. II. Effect of a valuable extract on some blood parameters in diabeticanimals. J. Ethnopharmacol. 1994, 3:167-171.
54. Sharma S.B., Balomajumder C., Roy P. Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem. Toxicol. 2008, 46:2376-2383.
55. Brown G.B., Xue-Qiao Z., Soccoand D.E., Albert J.J. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical vents in coronary disease. Circulation 1993, 8:1781-1791.
56. Eddouks M., Lemhadri A., Michel J.B. Hypolipidemic activity of aqueous extract of Cappariss pinosa L. in normal and diabetic rats. J. Ethnopharmacol. 2005, 98:345-350.
57. Ravi K., Rajasekaran S., Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem. Toxicol. 2005, 43:1433-1439.
58. Betterridge J. Lipid disorders in diabetes mellitus. Textbook of Diabetes 2002, 551-553. Blackwell Science. J. Pickup, G. Williams (Eds.).
59. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics 1985, Macmillan, New York, pp. 1490-1510.